Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 881 All time
- Disclosed funding
- $34.2B 795 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T Provides a unified API layer for cross-border payments and financial inclusion | $7.5M | Series A | Fintech | United States | Investors | |
| HA Highlight AICompany profile Builds a shared intelligence layer for teams and AI agents to unify work context across tools Builds a shared intelligence layer for teams and AI agents to unify work context across tools | $40M | Series A | AI | United States | Investors | |
| WC Working Capital PartnersCompany profile Provides structured capital solutions for elite talent in sports, music, and entertainment Provides structured capital solutions for elite talent in sports, music, and entertainment | $2B | Series A | Fintech | United States | Investors | |
| AT Amani TherapeuticsCompany profile Biotechnology company developing combination medicines for serious neuropsychiatric disorders. Biotechnology company developing combination medicines for serious neuropsychiatric disorders. | $25M | Series A | Biotech | United States | Investors | |
| GL Provides interactive, AR-powered kids' menus for independent restaurants | $6M | Series A | Foodtech | Australia | Investors | |
| N NamespaceCompany profile Developer infrastructure that provides fast coding, build and test environments for software teams. Developer infrastructure that provides fast coding, build and test environments for software teams. | Undisclosed | Series A | Developer tools | — | Investors | |
| OC Oryon Cell TherapiesCompany profile Develops autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders Develops autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders | $21M | Series A | Biotech | United States | Investors | |
| GL Gimlet LabsCompany profile Provides a cloud inference platform and compiler that distribute AI workloads across different processor types. Provides a cloud inference platform and compiler that distribute AI workloads across different processor types. | $80M | Series A | AI | United States | Investors | |
| E Develops autonomous harvesting robots for greenhouses | €8M | Series A | Agritech | Germany | Investors | |
| g games2getherCompany profile Player centric co-creation platform for studios to collaborate with communities Player centric co-creation platform for studios to collaborate with communities | €4.5M | Series A | Media & gaming | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.